Common Contracts

Contract

May 9th, 2018

• Filed
  May 9th, 2018

Amendment # 2 to Clinical Trial Agreement Dodatek # 2 ke Smlouvě o provedení klinického hodnocení By and Between mezi ARAGON PHARMACEUTICALS, INC,Pharmaceutical Research Associates CZ, s.r.o., Thomayerova nemocnice and ARAGON PHARMACEUTICALS, INC,Pharmaceutical Research Associates CZ, s.r.o., Thomayerova nemocnice a For ARN-509-003 pro ARN-509-003 This Amendment # 2 (the “Amendment # 2 “) by and among ARAGON PHARMACEUTICALS, INC, with offices located at 12780 El Camino Real, Suite 301, San Diego, CA 92130 ("Sponsor") represented by Pharmaceutical Research Associates CZ, s.r.o. by virtue of Delegation of authority datedand Thomayerova nemocnice with offices located at Vídeňská 800, Praha 4 – Krč, 140 59, Czech Republic Company ID number (IČ): 00064190, TAX ID number (DIČ): CZ00064190, represented by doc. MUDr. Zdeněk Beneš, CSc., director (the “Institution”) and(“Investigator”) located at Vídeňská 800, Praha4 – Krč, 140 59, Czech Republic and Pharmaceutical Research Associat